News – Page 1089 – Endpoints News

SIGN UP

Safety fears spur FDA to pause checkpoint combo studies by Bristol-Myers, Celgene

8 years ago

How your company can fund the work at Endpoints News — and give your employees complete access to our content

8 years ago

Publisher's note

Bioverativ climbs on board Bicycle's peptide platform in discovery deal; Ironwood CFO jumps ship, joins Vertex

8 years ago

Sarepta readies FDA pitch after a small study spotlights 1% dystrophin add for golodirsen in Duchenne MD

8 years ago

Rare obesity disease player Rhythm Pharma sets out in search of a $115M IPO windfall

8 years ago

Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal

8 years ago

Voyager Therapeutics adds proof its gene therapy for Parkinson's can work, shares soar

8 years ago

Verastem's low-stakes comeback gamble on an AbbVie/Infinity castoff pays off with positive CLL data

8 years ago

Here’s the inside account of Gilead's 11-week sprint to its $12B Kite buyout

8 years ago

ASCO spotlight presaged two more biotech IPOs angling for $215M

8 years ago

Cancer vax biotech Amal grabs $10M round; Global Blood Therapeutics eyes PRV with new FDA designation

8 years ago

OrbiMed lines up $551M gamble on China, India biotech sectors

8 years ago

Insmed shares soar as PhIII lung disease study proves positive, pointing to quick FDA pitch

8 years ago

Emboldened by recent R&D successes, Merck KGaA looks at selling off $1B-plus consumer division

8 years ago

In staggering setback, toxic reaction kills Cellectis’ first CAR-T patient, forcing trial halt

8 years ago

Takeda partners with Noile-Immune on next-gen CAR-T pipeline for solid tumors

8 years ago

Novartis follows up on big CAR-T win by naming Vas Narasimhan as its new CEO

8 years ago

Biogen vet Alpna Seth jumps to George Scangos' biotech startup; Top FDA scientist makes a leap to PhRMA

8 years ago

Doctors Without Borders say FDA's PRV incentive is misused; Teva drug wins FDA OK on tardive dyskinesia

8 years ago

NEA-backed Nightstar Therapeutics sets sights on an $86M IPO to fund PhIII gene therapy study

8 years ago

Troubled Acorda hurries to bar the door against a takeover attempt

8 years ago

Neurotoxicity kills a CAR-T rival pushed by J&J, MacroGenics in $700M deal

8 years ago

The top 10 biopharma CROs in the world—mid-2017 edition

8 years ago

Feds scoop up a band of biotech insiders who allegedly bagged a windfall, and now criminal charges

8 years ago

First page Previous page 1086 1087 108810891090 1091 1092 Next page Last page